Who owns the CENYX BIOTECH trademark?

The CENYX BIOTECH trademark is owned by Cenyx Biotech Inc..

What is the serial number for CENYX BIOTECH?

The USPTO serial number for CENYX BIOTECH is 79343374.

What is the registration number for CENYX BIOTECH?

CENYX BIOTECH is registered under USPTO registration number 7333739.

CEN

USPTO Trademark Record

REGISTERED

CENYX BIOTECH

Q: What class is the CENYX BIOTECH trademark registered in?

The CENYX BIOTECH trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79343374·Reg 7333739·Filed Apr 29, 2022

Owner Cenyx Biotech Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CENYX BIOTECH (Serial No. 79343374), Registration No. 7333739, is a registered US trademark filed on Apr 29, 2022 by Cenyx Biotech Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: March 26, 2030

Mark Intelligence

CENYX BIOTECH (Reg. #7333739) is a registered US trademark that has been protecting its owner, Cenyx Biotech Inc., since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 6 opposition proceedings during prosecution.

FILED

Apr 29, 2022

SERIAL

79343374

REG#

7333739

REGISTERED

Mar 26, 2024

Owner

Applicant

Cenyx Biotech Inc.

Entity

Corporation

Address

51bench, Collaborating laboratory 2B, 101,, Daehak-ro, Jongno-gu Seoul 03080

Country

Attorney

NameLeigh Ann Lindquist

Law firm

Leigh Ann Lindquist SUGHRUE MION, PLLC

Docket

S26527

Address

2000 Pennsylvania Avenue NW, Suite 9000, Washington, DC 20006, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 29, 2022

Serial Number79343374

Registration No.7333739

Registration DateMar 26, 2024

Status DateMar 26, 2024

Published for OppositionJan 09, 2024

Mark TypeStandard characters

Attorney DocketS26527

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 6× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

34 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 17, 2024

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Oct 06, 2024

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Oct 06, 2024

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 27, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Mar 26, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 26, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 09, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 09, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Jan 08, 2024

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 20, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Dec 20, 2023

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Dec 20, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Dec 18, 2023

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Nov 29, 2023

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

EXAMINERS AMENDMENT -WRITTEN

Nov 29, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Nov 29, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 29, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Nov 29, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 29, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Nov 29, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

ASSIGNED TO EXAMINER

Nov 07, 2023

ASSIGNED TO EXAMINER

Nov 05, 2023

ASSIGNED TO EXAMINER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 24, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 24, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 24, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

May 24, 2023

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Apr 30, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Apr 30, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 11, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Mar 10, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Feb 17, 2023

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Jun 28, 2022

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 24, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jun 23, 2022

SN ASSIGNED FOR SECT 66A APPL FROM IB

CENYX BIOTECH

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Cenyx Biotech Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Leigh Ann Lindquist

Industries

USPTO Deadlines

Compare

Resources

Company